Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.55 |
| ▸ | MRGPRX4 | Q96LA9 | 4/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 4/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8623269 | 0.91 | HIF1A (0.50) | HIF1AMRGPRX4FFAR4FFAR1 | |
| SCHEMBL8589674 | 0.91 | HIF1A (0.50) | HIF1AMRGPRX4FFAR4FFAR1 | |
| SCHEMBL8622089 | 0.89 | MRGPRX4 (0.54) | HIF1AMRGPRX4FFAR4FFAR1 | |
| SCHEMBL8622088 | 0.89 | MRGPRX4 (0.54) | HIF1AMRGPRX4FFAR4FFAR1 | |
| SCHEMBL435569 | 0.88 | HIF1A (0.51) | HIF1ATP53HTT | |
| SCHEMBL6899784 | 0.88 | HIF1A (0.51) | HIF1ATP53HTT | |
| SCHEMBL435570 | 0.88 | HIF1A (0.51) | HIF1ATP53HTT | |
| SCHEMBL8655544 | 0.88 | HIF1A (0.48) | HIF1AMRGPRX4FFAR4FFAR1FOLH1 | |
| SCHEMBL8655549 | 0.88 | HIF1A (0.48) | HIF1AMRGPRX4FFAR4FFAR1FOLH1 | |
| SCHEMBL7597717 | 0.87 | HIF1A (0.49) | HIF1AMRGPRX4FFAR4FFAR1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6482984-B2 | FOR CONTROLLING HARMFUL FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-19 | — | — | US | disclosed |
| US-20020082303-A1 | Iminooxy-substituted benzyl phenyl ethers, processes and intermediates for their preparation, compositions comprising them, and their use for controlling harmful fungi | BASF AKTIENGESELLSCHAFT (DE) | 2002-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020082303-A1 | Iminooxy-substituted benzyl phenyl ethers, processes and intermediates for their preparation, compositions comprising them, and their use for controlling harmful fungi | CBR3, CFH, CNPY3 | HIF1A 830/4885MRGPRX4 1715/4885FFAR4 3982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.